Literature DB >> 21057479

Chinese hamster ovary cells can produce galactose-α-1,3-galactose antigens on proteins.

Carlos J Bosques, Brian E Collins, James W Meador, Hetal Sarvaiya, Jennifer L Murphy, Guy Dellorusso, Dorota A Bulik, I-Hsuan Hsu, Nathaniel Washburn, Sandra F Sipsey, James R Myette, Rahul Raman, Zachary Shriver, Ram Sasisekharan, Ganesh Venkataraman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21057479      PMCID： PMC4005363          DOI： 10.1038/nbt1110-1153

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

Review 1.  Getting the glycosylation right: implications for the biotechnology industry.

Authors:  N Jenkins; R B Parekh; D C James
Journal:  Nat Biotechnol       Date:  1996-08       Impact factor: 54.908

2.  Structural basis of ordered binding of donor and acceptor substrates to the retaining glycosyltransferase, alpha-1,3-galactosyltransferase.

Authors:  Ester Boix; Yingnan Zhang; G Jawahar Swaminathan; Keith Brew; K Ravi Acharya
Journal:  J Biol Chem       Date:  2002-05-14       Impact factor: 5.157

3.  Active site studies of bovine alpha1-->3-galactosyltransferase and its secondary structure prediction.

Authors:  P S Shah; F Bizik; R K Dukor; P K Qasba
Journal:  Biochim Biophys Acta       Date:  2000-07-14

4.  Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose.

Authors:  D M Sheeley; B M Merrill; L C Taylor
Journal:  Anal Biochem       Date:  1997-04-05       Impact factor: 3.365

5.  Isolation of a cDNA encoding a murine UDPgalactose:beta-D-galactosyl- 1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer.

Authors:  R D Larsen; V P Rajan; M M Ruff; J Kukowska-Latallo; R D Cummings; J B Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Conformational changes induced by binding UDP-2F-galactose to alpha-1,3 galactosyltransferase- implications for catalysis.

Authors:  Haryati Jamaluddin; Percy Tumbale; Stephen G Withers; K Ravi Acharya; Keith Brew
Journal:  J Mol Biol       Date:  2007-04-12       Impact factor: 5.469

7.  Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.

Authors:  Christine H Chung; Beloo Mirakhur; Emily Chan; Quynh-Thu Le; Jordan Berlin; Michael Morse; Barbara A Murphy; Shama M Satinover; Jacob Hosen; David Mauro; Robbert J Slebos; Qinwei Zhou; Diane Gold; Tina Hatley; Daniel J Hicklin; Thomas A E Platts-Mills
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

8.  Roles of active site tryptophans in substrate binding and catalysis by alpha-1,3 galactosyltransferase.

Authors:  Yingnan Zhang; Ashlesha Deshpande; Zhihong Xie; Ramanathan Natesh; K Ravi Acharya; Keith Brew
Journal:  Glycobiology       Date:  2004-06-30       Impact factor: 4.313

Review 9.  The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance.

Authors:  Bruce A Macher; Uri Galili
Journal:  Biochim Biophys Acta       Date:  2007-11-22
  9 in total
  44 in total

1.  Rapid Fc glycosylation analysis of Fc fusions with IdeS and liquid chromatography mass spectrometry.

Authors:  Heather Lynaugh; Huijuan Li; Bing Gong
Journal:  MAbs       Date:  2013-06-20       Impact factor: 5.857

2.  2nd Charles Richet et Jules Héricourt workshop: therapeutic antibodies and anaphylaxis; May 31-June 1, 2011, Tours, France.

Authors:  Arnaud Daguet; Hervé Watier
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

3.  Anti-galactose-α-1,3-galactose IgE from allergic patients does not bind α-galactosylated glycans on intact therapeutic antibody Fc domains.

Authors:  Jeroen J Lammerts van Bueren; Theo Rispens; Sandra Verploegen; Tjitske van der Palen-Merkus; Steven Stapel; Lisa J Workman; Hayley James; Patrick H C van Berkel; Jan G J van de Winkel; Thomas A E Platts-Mills; Paul W H I Parren
Journal:  Nat Biotechnol       Date:  2011-07-11       Impact factor: 54.908

4.  Function characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro.

Authors:  Chang-hong Yi; Can-ping Ruan; Hao Wang; Xin-yun Xu; Yun-peng Zhao; Meng Fang; Jun Ji; Xing Gu; Chun-fang Gao
Journal:  Acta Pharmacol Sin       Date:  2014-09-29       Impact factor: 6.150

Review 5.  Using glyco-engineering to produce therapeutic proteins.

Authors:  Martina Dicker; Richard Strasser
Journal:  Expert Opin Biol Ther       Date:  2015-07-14       Impact factor: 4.388

6.  Glycomic profiling of glycoproteins.

Authors:  Jarkko Räbinä
Journal:  Glycoconj J       Date:  2013-02       Impact factor: 2.916

Review 7.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

8.  Identification of the binding roles of terminal and internal glycan epitopes using enzymatically synthesized N-glycans containing tandem epitopes.

Authors:  Zhigang Wu; Yunpeng Liu; Cheng Ma; Lei Li; Jing Bai; Lauren Byrd-Leotis; Yi Lasanajak; Yuxi Guo; Liuqing Wen; He Zhu; Jing Song; Yanhong Li; David A Steinhauer; David F Smith; Baohua Zhao; Xi Chen; Wanyi Guan; Peng George Wang
Journal:  Org Biomol Chem       Date:  2016-11-29       Impact factor: 3.876

9.  Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.

Authors:  Lei Zhu; Qingcheng Guo; Huaizu Guo; Tao Liu; Yingxin Zheng; Peiming Gu; Xi Chen; Hao Wang; Sheng Hou; Yajun Guo
Journal:  MAbs       Date:  2014       Impact factor: 5.857

10.  N-glycan analysis of human α1-antitrypsin produced in Chinese hamster ovary cells.

Authors:  Kyung Jin Lee; Sang Mee Lee; Jin Young Gil; Ohsuk Kwon; Jin Young Kim; Soon Jae Park; Hye-Shin Chung; Doo-Byoung Oh
Journal:  Glycoconj J       Date:  2012-10-12       Impact factor: 2.916
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.